These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1964911)

  • 1. Peptide receptor antagonists in the study of insulin and glucagon secretion in mice.
    Karlsson S; Ahrén B
    Eur J Pharmacol; 1990 Dec; 191(3):457-64. PubMed ID: 1964911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.
    Karlsson S; Ahrén B
    Acta Physiol Scand; 1989 Mar; 135(3):271-8. PubMed ID: 2648765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and glucagon secretion in the rat: effects of gastrin releasing peptide.
    Pettersson M; Ahrén B
    Neuropeptides; 1988 Oct; 12(3):159-63. PubMed ID: 3071743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cholecystokinin and gastrin antagonists on pancreatic exocrine secretion stimulated by gastrin-releasing peptide.
    Terashima H; Debas HT; Bunnett NW
    Pancreas; 1992; 7(2):212-9. PubMed ID: 1553370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrin releasing peptide (GRP): effects on basal and stimulated insulin and glucagon secretion in the mouse.
    Pettersson M; Ahrén B
    Peptides; 1987; 8(1):55-60. PubMed ID: 3554168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cholecystokinin, gastrin and gastrin-releasing peptide in the regulation of pancreatic secretion in cats.
    Konturek SJ; Bilski J; Hladij M; Krzyzek E; Cai RZ; Schally AV
    Digestion; 1991; 49(2):97-105. PubMed ID: 1724767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice.
    Ahrén B; Gingerich RL; Havel PJ
    Regul Pept; 1995 Nov; 59(3):297-302. PubMed ID: 8577934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of peptide YY on insulin release stimulated by 2-deoxyglucose and neuropeptides in dogs.
    Guo YS; Singh P; DeBouno JF; Thompson JC
    Pancreas; 1988; 3(2):128-34. PubMed ID: 3287367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin secretion by gastrin-releasing peptide in mice: ganglionic versus direct islet effect.
    Karlsson S; Sundler F; Ahrén B
    Am J Physiol; 1998 Jan; 274(1):E124-9. PubMed ID: 9458757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrin releasing peptide stimulates the secretion of insulin, but not that of glucagon or somatostatin, from the isolated perfused dog pancreas.
    Hermansen K; Ahrén B
    Acta Physiol Scand; 1990 Feb; 138(2):175-9. PubMed ID: 1969219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of substance P and other peptides on the release of somatostatin, insulin, and glucagon in vitro.
    Hermansen K
    Endocrinology; 1980 Jul; 107(1):256-61. PubMed ID: 6155261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptide in mice.
    Ahrén B; Hughes TE
    Endocrinology; 2005 Apr; 146(4):2055-9. PubMed ID: 15604213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific inhibitor of CCK-receptor binding.
    Rossetti L; Shulman GI; Zawalich WS
    Diabetes; 1987 Oct; 36(10):1212-5. PubMed ID: 3308589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal capsaicin-treatment in mice: effects on pancreatic peptidergic nerves and 2-deoxy-D-glucose-induced insulin and glucagon secretion.
    Karlsson S; Sundler F; Ahrén B
    J Auton Nerv Syst; 1992 Jun; 39(1):51-9. PubMed ID: 1378463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of receptors for gastrin, cholecystokinin and GRP/bombesin in postprandial stimulation of exocrine pancreas in dogs.
    Konturek SJ; Tasler J; Bilski J; Cieszkowski M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1993 Mar; 44(1):43-53. PubMed ID: 8390873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of L-364,718 on GRP-stimulated pancreatic and gastric secretions and GI peptides in conscious dogs.
    Hosotani R; Chowdhury P; Huang YS; McKay D; Yajima H; Rayford PL
    Pancreas; 1989; 4(5):550-5. PubMed ID: 2813326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin-releasing peptide and cholecystokinin in the regulation of exocrine pancreatic secretion in dogs.
    Nustede R; Schmidt WE; Lohmann C; Köhler H; Schlemminger R; Schafmayer A
    Digestion; 1993; 54(2):79-83. PubMed ID: 8319843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
    J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of gastrin-releasing peptide on the endocrine pancreas.
    McDonald TJ; Houghton P; Challis JR; Hramiak IM
    Ann N Y Acad Sci; 1988; 547():242-54. PubMed ID: 3071222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet function phenotype in gastrin-releasing peptide receptor gene-deficient mice.
    Persson K; Pacini G; Sundler F; Ahrén B
    Endocrinology; 2002 Oct; 143(10):3717-26. PubMed ID: 12239081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.